Dorota Dobler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dorota Dobler has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Frank Runkel
Department of Life Science Engineering, Institute of Bioprocess Engineering and Pharmaceutical Technology, Technische Hochschule Mittelhessen—University of Applied Sciences, Wiesenstrasse 14, 35390 Giessen, Germany
3 shared publications Thomas Schmidts
Technische Hochschule Mittelhessen - University of Applied Sciences, Institute of Bioprocess Engineering and Pharmaceutical Technology, Wiesenstr. 14, 35390 Giessen, Germany; Novigo GmbH & Co. KG - Anwenderzentrum Technische Hochschule, Ringallee 34, 35390 Giessen, Germany
3 shared publicationsFrank Runkel
Institute of Bioprocess Engineering and Pharmaceutical Technology Technische Hochschule Mittelhessen ‐ University of Applied Sciences Giessen Germany
2 shared publications- Thomas Schmidts
Technische Hochschule Mittelhessen, Institute of Bioprocess Engineering and Pharmaceutical Technology, 35390 Giessen, Germany
2 shared publications - Anna-Carola Eicher
Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen, Wiesenstraße 14, 35390 Giessen, Germany
1 shared publication Harald Renz
Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostic, Baldinger Strasse, 35043 Marburg, Philipps-University Marburg, Germany
1 shared publication
Latest Publications
- Open Access
- 22 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2552
Comparative Ungual Drug Uptake Studies: Equine Hoof Membrane vs. Human Nail Plate
Human nail diseases, mostly caused by fungal infections, are common and difficult to treat. The development and testing of new drugs and drug delivery systems for the treatment of nail diseases is often limited by the lack of human nail material for permeation studies. Animal material is frequently used, but there are only few comparative data on the human nail plate, and there is neither a standardized test design nor a nail bed analogue to study drug uptake into the nail. In this study, a new permeation device was developed for permeation studies, and the permeation behavior of three model substances on the human nail plate and a model membrane from the horse hoof was investigated. A linear correlation was found between drug uptake by the human nail plate and the uptake by the equine hoof. The developed and established permeation device is suitable for investigations of ungual drug transport and enables the use of different membrane diameters and the use of a gel-based nail bed analog. The hydrogel-based acceptor medium used ensures adequate stabilization and hydration of the nail membrane.
- 22 November 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (12) , 2552
Open AccessComparative Ungual Drug Uptake Studies: Equine Hoof Membrane vs. Human Nail Plate
Human nail diseases, mostly caused by fungal infections, are common and difficult to treat. The development and testing of new drugs and drug delivery systems for the treatment of nail diseases is often limited by the lack of human nail material for permeation studies. Animal material is frequently used, but there are only few comparative data on the human nail plate, and there is neither a standardized test design nor a nail bed analogue to study drug uptake into the nail. In this study, a new permeation device was developed for permeation studies, and the permeation behavior of three model substances on the human nail plate and a model membrane from the horse hoof was investigated. A linear correlation was found between drug uptake by the human nail plate and the uptake by the equine hoof. The developed and established permeation device is suitable for investigations of ungual drug transport and enables the use of different membrane diameters and the use of a gel-based nail bed analog. The hydrogel-based acceptor medium used ensures adequate stabilization and hydration of the nail membrane.
- 1 May 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (5) , 1414-1420
Salicylate-Based Ionic Liquids as Innovative Ingredients in Dermal Formulations
- 1 May 2022
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 111 (5) , 1414-1420
Salicylate-Based Ionic Liquids as Innovative Ingredients in Dermal Formulations
- Open Access
- 17 November 2020
- Published by Wiley in European Journal of Oral Sciences
- Vol. 128 (6) , 476-486
Effect of essential oils on oral halitosis treatment: a review
Halitosis is a very common condition which may affect up to 30% of the population. In about 90% of the cases, halitosis originates in the mouth due to inadequate plaque control, periodontal disease, dry mouth, faulty restorations, and in particular due to excessive bacterial growth. Oral malodor is mainly caused by a microbial degradation of amino acids into volatile, bad‐smelling gases (volatile sulfur compounds – VSCs). Management of oral malodor is directed primarily at managing and reducing the VSC‐producing bacteria count as well as masking the odor. Essential oils have been used for this purpose in traditional medicine for centuries. In the present review, data on the antimicrobial activity of essential oils against relevant oral VSC‐producing bacteria are compiled and compared. Additionally, other positive aspects of essential oils with regard to oral odor are considered.
- 17 November 2020
- Published by Wiley in European Journal of Oral Sciences
- Vol. 128 (6) , 476-486
Open AccessEffect of essential oils on oral halitosis treatment: a review
Halitosis is a very common condition which may affect up to 30% of the population. In about 90% of the cases, halitosis originates in the mouth due to inadequate plaque control, periodontal disease, dry mouth, faulty restorations, and in particular due to excessive bacterial growth. Oral malodor is mainly caused by a microbial degradation of amino acids into volatile, bad‐smelling gases (volatile sulfur compounds – VSCs). Management of oral malodor is directed primarily at managing and reducing the VSC‐producing bacteria count as well as masking the odor. Essential oils have been used for this purpose in traditional medicine for centuries. In the present review, data on the antimicrobial activity of essential oils against relevant oral VSC‐producing bacteria are compiled and compared. Additionally, other positive aspects of essential oils with regard to oral odor are considered.
- Open Access
Impact of Selected Cosmetic Ingredients on Common Microorganisms of Healthy Human Skin
Human skin is a complex ecosystem and is host to a large number of microorganisms. When the bacterial ecosystem is balanced and differentiated, skin remains healthy. However, the use of cosmetics can change this balance and promote the appearance of skin diseases. The skin’s microorganisms can utilize some cosmetic components, which either promote their growth, or produce metabolites that influence the skin environment. In this study, we tested the ability of the Malassezia species and some bacterial strains to assimilate substances frequently used in dermal formulations. The growth capability of microorganisms was determined and their lipase activity was analyzed. The growth of all Malassezia spp. in the presence of free acids, free acid esters, and fatty alcohols with a fatty chain length above 12 carbon atoms was observed. No growth was observed in the presence of fatty alcohol ethers, secondary fatty alcohols, paraffin- and silicon-based substances, polymers, polyethylene glycols, quaternary ammonium salts, hydroxy fatty acid esters, or fatty acids and fatty acid esters with a fatty chain length shorter than 12 carbon atoms. The hydrolysis of esters by Malassezia lipases was detected using High Performance Thin Layer Chromatography (HPTLC). The production of free fatty acids as well as fatty alcohols was observed. The growth promotion or inhibition of bacterial strains was only found in the presence of a few ingredients. Based on these results, formulations containing microbiome inert ingredients were developed.
Open AccessImpact of Selected Cosmetic Ingredients on Common Microorganisms of Healthy Human Skin
Human skin is a complex ecosystem and is host to a large number of microorganisms. When the bacterial ecosystem is balanced and differentiated, skin remains healthy. However, the use of cosmetics can change this balance and promote the appearance of skin diseases. The skin’s microorganisms can utilize some cosmetic components, which either promote their growth, or produce metabolites that influence the skin environment. In this study, we tested the ability of the Malassezia species and some bacterial strains to assimilate substances frequently used in dermal formulations. The growth capability of microorganisms was determined and their lipase activity was analyzed. The growth of all Malassezia spp. in the presence of free acids, free acid esters, and fatty alcohols with a fatty chain length above 12 carbon atoms was observed. No growth was observed in the presence of fatty alcohol ethers, secondary fatty alcohols, paraffin- and silicon-based substances, polymers, polyethylene glycols, quaternary ammonium salts, hydroxy fatty acid esters, or fatty acids and fatty acid esters with a fatty chain length shorter than 12 carbon atoms. The hydrolysis of esters by Malassezia lipases was detected using High Performance Thin Layer Chromatography (HPTLC). The production of free fatty acids as well as fatty alcohols was observed. The growth promotion or inhibition of bacterial strains was only found in the presence of a few ingredients. Based on these results, formulations containing microbiome inert ingredients were developed.
- 1 February 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 479 (1) , 150-158
Development of a protective dermal drug delivery system for therapeutic DNAzymes
- 1 February 2015
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 479 (1) , 150-158
Development of a protective dermal drug delivery system for therapeutic DNAzymes